Search Results 1191-1200 of 21695 for Inhibition

1. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer - Mayo Clinic

   ... inhibitors such as omeprazole within 14 days prior to first dose of study drug. Participating Mayo Clinic locations. Study statuses change often. Please ...

2. A Study Of Simvastatin Therapy For Moderate And Severe COPD - Mayo Clinic

   ... inhibitors (such as indinavir), amiodarone, gemfibrozil, cyclosporine, verapamil, danazol, nefazodone, and red yeast rice extracts; Active liver disease ...

3. Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma - Mayo Clinic

   ... inhibitors, or low molecular weight heparin at therapeutic doses; Patient ... inhibitors or warfarin; patients unable or unwilling to take any prophylaxis are NOT ...

4. Topical Tranexamic Acid in Complex Cardiac Surgery: Does it Reduce Transfusion Need? - Mayo Clinic

   Patients with coagulopathic conditions such as factor deficiencies, factor inhibitors, heparin induced thrombocytopenia, or use of intravenous anticoagulants ...

5. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

   Complement inhibitors (e.g., eculizumab) within 6 months prior to screening. Glatiramer acetate and IFN-β within 1 month prior to screening. Fumarates ...

6. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   One of the prior therapies must have included a proteosome inhibitor or an immunomodulatory drug; Measurable disease as defined by protocol. Exclusion ...

7. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   Grade 2 or Grade 3 pneumonitis or any other Grade 3 checkpoint inhibitor-related toxicity that led to immunotherapy treatment discontinuation. Low-grade ...

8. MAYO CLINIC HEALTH LETTER

   Serotonin and nor- epinephrine reuptake inhibitor (SNRI) antidepressant drugs — such as dulox- etine (Cymbalta), venlafaxine, or mil- nacipran (Savella) — have ...

9. A Study Of Latanoprost In Open Angle Glaucoma And Ocular Hypertension Patients - Mayo Clinic

   ... inhibitors, angiotensin II receptor blockers. Recent change in medications that are known to affect IOP within 30 days prior to the screening visit and ...

10. Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

    Willingness to stop use of strong inducers or inhibitors of CYP3A4 prior to registration. Note: Use of strong inducers or inhibitors is allowed during Pre ...